EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Liposomal-Mitoxantrone Overcomes Acquired Resistance and Enhances Venetoclax Synergy in AML-Mechanistic Insights and Preliminary Clinical Evidence

Kunpeng Luo iD, Yan Hui, Heng Shen, Lin Yan, Yu Zeng, Luyao Zhou, Min Wang, Jianxiang Wang, Mingcheng Liu, Hui Wei

International Journal of Nanomedicine · 2026

DOI: 10.2147/ijn.s634276 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Kunpeng Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute …. Hauptthemen laut MEDLINE: Sulfonamides, Leukemia, Myeloid, Acute, Liposomes, Bridged Bicyclo Compounds, Heterocyclic. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SulfonamidesLeukemia, Myeloid, AcuteLiposomesBridged Bicyclo Compounds, HeterocyclicDrug Resistance, NeoplasmMitoxantroneAntineoplastic AgentsAnimalsMiceHumansDrug SynergismCell Line, TumorFemaleAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

acute myeloid leukemiadrug combinationliposomal-mitoxantronevenetoclax

Substanzen

SulfonamidesLiposomesvenetoclaxBridged Bicyclo Compounds, HeterocyclicMitoxantroneAntineoplastic Agents

Autor:innen und Institutionen

  • State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sc…
  • Tianjin Institutes of Health Science, Tianjin, People's Republic of China.

ORCID-Profile: Kunpeng Luo

Zitieren

APA

Luo, K., Hui, Y., Shen, H., Yan, L., Zeng, Y., Zhou, L., Wang, M., Wang, J., Liu, M., & Wei, H. (2026). Liposomal-Mitoxantrone Overcomes Acquired Resistance and Enhances Venetoclax Synergy in AML-Mechanistic Insights and Preliminary Clinical Evidence. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s634276

Vancouver

Luo K, Hui Y, Shen H, Yan L, Zeng Y, Zhou L, et al. Liposomal-Mitoxantrone Overcomes Acquired Resistance and Enhances Venetoclax Synergy in AML-Mechanistic Insights and Preliminary Clinical Evidence. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s634276

BibTeX
@article{Luo2026,
  author = {Luo, Kunpeng and Hui, Yan and Shen, Heng and Yan, Lin and Zeng, Yu and Zhou, Luyao and Wang, Min and Wang, Jianxiang and Liu, Mingcheng and Wei, Hui},
  title = {Liposomal-Mitoxantrone Overcomes Acquired Resistance and Enhances Venetoclax Synergy in AML-Mechanistic Insights and Preliminary Clinical Evidence},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  doi = {10.2147/ijn.s634276}
}
Kostenlos starten →